BRAINSTORM CELL THERAPEUTICS INC. 10KSB, filed Apr 14, 2008: ex32-2.htm
EXHIBIT
32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.
In
connection with the accompanying Annual Report on Form 10-KSB of Brainstorm
Cell
Therapeutics Inc. for the year ended December 31, 2007, the undersigned hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906
of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
that:
(1)
such
Annual Report on Form 10-KSB for the year ended December 31, 2007 fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act
of 1934; and
(2)
the
information contained in such Annual Report on Form 10-KSB for the year ended
December 31, 2007 fairly presents, in all material respects, the financial
condition and results of operations.
|
April
14, 2008
|
/s/
David Stolick
|
|
|
Name:
David Stolick
|
|
|
Title:
Chief Financial Officer (Principal Financial
Officer)
|